top of page
GBX_EVENTS_2024_womeninscience_#GBX_Staff_#CGTI_#BILS_DDIF_#MEVO
GBX Events Icon

17th Annual Bio Innovation Leaders Summit 2025

12th & 13th February 2025
Raffles Singapore

Jens H. Vogel

President & COO of Mirai Bio - Former CEO of BI Fremont & Global Head of Biotech at Bayer Pharmaceuticals

Jens H. Vogel, Previous SVP & Global Biotech at Bayer is an advisor of The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025

Uwe Gottschalk

Operating Partner at Keensight Capital - Former CSO of Lonza

Uwe Gottschalk, Operating Partner at Keensight Capital - Previous CSO of Lonza is an advisor of The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025

Jesse McCool

CSO of Bionova Scientific - Former Co-Founder & CEO of Wheeler Bio

Jesse McCool, Co-Founder & CEO of Wheeler Bio is an advisor of The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025

Angela Vollstedt

Global R&D Director Cell & Gene Therapies Portfolio at Novartis

Angela Vollstedt, Global Director, Cell & Gene Therapies Portfolio Management at Novartis is an advisor of The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025
Behzad Mahdavi, CEO & Board Member at InnoGi Technologies #BILS is an advisor of The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025

Behzad Mahdavi

CEO & Board member at InnoGI Technologies & Executive Chairman at Open Cell Technologies

Push boundaries, affect change

BILS 2025. The 17th Annual Bio Innovation Leaders Summit brings together c-suite, executives, pioneering thinkers and leading academics who are committed to breaking free from traditional silos to evolve and make an impact. Our curated programme is for leaders interested in strategy and innovation that will harness the full potential of the development of promising biologics and cell and gene therapies.  

 

Agenda Framework 

  • Empowering innovation in therapeutic proteins

  • The pursuit of excellence in innovative biologics

  • The convergence of Cell Science: Exploring synergies between biopharma and cultivated meat

  • Cutting edge and agile CDMO’s

  • Evolution of global supply chain pressuring COGS, impacting scalability and commercialisation​

  • CarT 2.0 - innovative advanced potential of CarT therapies

  • To bring maximal benefit for patients we need to excel in technological development 

  • Strategic donor sourcing to enhance quality and minimise variability of allogenic cells

Impromptu testimonials

A picture of staff at The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025
A picture of staff at The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025
Learn more

Confirmed Speakers

Learn more

Register Interest

A picture of staff at The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025
Learn more

Programme

CURRENT ​SPEAKERS 

A picture of staff at The 17th Annual Bio Innovation Leaders Summit #BILS 2025 which is taking place in the Raffles Singapore on the 12th & 13th of February 2025

AGENDA SCHEDULE

Biologics

  • Risk sharing partnerships CDMO

  • Advance manufacturing

  • Single use innovation

  • Digital Twins

  • Process intensification 

  • Process validation 

  • Biologic workflow solutions

  • Bioprocessing Training

  • Quality control and analysis

  • Predict clinical outcomes

  • Impact global suppychain

  • Modular CDMO - site selection

  • Safety and Efficiency

  • Automation, digitising, robotics

  • Process optimisation

  • Leverage Regulatory Pathways

  • Cell engineering & development

  • Scaling and commercialisation

  • Customer acceptance 

  • Survival -  Valley of Death  

  • Regulatory frameworks 

  • Continuous processing

  • Technologies roles in culinary innovation

  • Investor roadmap 

  • Cultivated meat tasting